Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
Primary Purpose
Dystonia, Drug Induced Dystonia, Parkinson Disease
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
DystoniaNet-based diagnosis of isolated dystonia
Sponsored by
About this trial
This is an interventional diagnostic trial for Dystonia
Eligibility Criteria
Inclusion criteria:
- Males and females of diverse racial and ethnic backgrounds, with age across the lifespan;
- Patients will have at least one of the forms of dystonia, including focal dystonia (e.g., laryngeal, cervical, oromandibular, blepharospasm, focal hand, musicians), segmental dystonia, or generalized dystonia;
- Patients will have other movement disorders (Parkinson's disease, essential tremor, dyskinesia, myoclonus) and other non-neurological conditions (tic disorders, torticollis, ulnar nerve entrapments, temporomandibular disorders, dysphonia) that mimic dystonic symptoms.
Exclusion criteria:
- Patients who are incapable of giving informed consent;
- Patients who are unable to undergo brain MRI due to the presence of certain tattoos and ferromagnetic objects in their bodies (e.g., implanted stimulators, surgical clips, prosthesis, artificial heart valve) that cannot be removed or due to pregnancy or breastfeeding at the time of the study.
Sites / Locations
- Massachusetts Eye and Ear InfirmaryRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Retrospective clinical validation of DystoniaNet
Prospective clinical validation of DystoniaNet
Arm Description
Retrospective studies will (1) clinically validate the diagnostic performance of DystoniaNet compared to a normal neurological state (normative test), and (2) develop and test DystoniaNet extensions in comparison with other neurological and non-neurological conditions (differential test).
Prospective randomized studies will validate DystoniaNet performance for accurate, objective, and fast diagnosis of dystonia in the actual clinical setting.
Outcomes
Primary Outcome Measures
Correctness of clinical diagnosis of dystonia using the DystoniaNet algorithm
Correctness of dystonia diagnosis (yes dystonia/no dystonia) will be established using the DystoniaNet machine-learning algorithm
Time of clinical diagnosis of dystonia using the DystoniaNet algorithm
The length of time (in months) from symptom onset to clinical diagnosis will be established using the DystoniaNet machine-learning algorithm
Secondary Outcome Measures
Full Information
NCT ID
NCT05317390
First Posted
November 28, 2021
Last Updated
October 24, 2023
Sponsor
Massachusetts Eye and Ear Infirmary
1. Study Identification
Unique Protocol Identification Number
NCT05317390
Brief Title
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
Official Title
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
April 30, 2027 (Anticipated)
Study Completion Date
April 30, 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts Eye and Ear Infirmary
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.
Detailed Description
Isolated dystonia is a movement disorder of unknown pathophysiology, which causes involuntary muscle contractions leading to abnormal, typically patterned, twisting movements and postures. A significant challenge in the clinical management of dystonia is due to the absence of a biomarker and associated 'gold' standard diagnostic test. Currently, the diagnosis of dystonia is guided by clinical evaluations of its symptoms, which lead to a low agreement between clinicians and a high rate of diagnostic inaccuracies. It is estimated that only 5% of patients receive an accurate diagnosis at symptom onset, and the average diagnostic delay extends up to 10.1 years. This study will conduct retrospective and prospective studies to clinically validate the performance of DystoniaNet, a biomarker-based deep learning platform for the diagnosis of isolated dystonia.
The retrospective studies will clinically validate the diagnostic performance of the DystoniaNet algorithm (1) in patients compared to healthy subjects (normative test), and (2) between patients with dystonia and other neurological and non-neurological conditions (differential test).
The prospective randomized study will validate the performance of DystoniaNet algorithm for accurate, objective, and fast diagnosis of dystonia in the actual clinical setting.
This research is expected to advance the DystoniaNet algorithm for dystonia diagnosis into its clinical use for increased accuracy of dystonia diagnosis. Early detection and diagnosis of dystonia will enable its early therapy and improved prognosis, having an overall positive impact on healthcare and patients' quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dystonia, Drug Induced Dystonia, Parkinson Disease, Essential Tremor, Dyskinesias, Myoclonus, Tic Disorders, Torticollis, Ulnar Nerve Entrapment, Temporomandibular Joint Disorders, Dysphonia
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
1000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Retrospective clinical validation of DystoniaNet
Arm Type
No Intervention
Arm Description
Retrospective studies will (1) clinically validate the diagnostic performance of DystoniaNet compared to a normal neurological state (normative test), and (2) develop and test DystoniaNet extensions in comparison with other neurological and non-neurological conditions (differential test).
Arm Title
Prospective clinical validation of DystoniaNet
Arm Type
Experimental
Arm Description
Prospective randomized studies will validate DystoniaNet performance for accurate, objective, and fast diagnosis of dystonia in the actual clinical setting.
Intervention Type
Diagnostic Test
Intervention Name(s)
DystoniaNet-based diagnosis of isolated dystonia
Intervention Description
DystoniaNet will be used for the diagnosis of dystonia and its differential diagnosis from other neurological and non-neurological disorders mimicking symptoms of dystonia
Primary Outcome Measure Information:
Title
Correctness of clinical diagnosis of dystonia using the DystoniaNet algorithm
Description
Correctness of dystonia diagnosis (yes dystonia/no dystonia) will be established using the DystoniaNet machine-learning algorithm
Time Frame
4 years
Title
Time of clinical diagnosis of dystonia using the DystoniaNet algorithm
Description
The length of time (in months) from symptom onset to clinical diagnosis will be established using the DystoniaNet machine-learning algorithm
Time Frame
4 years
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria:
Males and females of diverse racial and ethnic backgrounds, with age across the lifespan;
Patients will have at least one of the forms of dystonia, including focal dystonia (e.g., laryngeal, cervical, oromandibular, blepharospasm, focal hand, musicians), segmental dystonia, or generalized dystonia;
Patients will have other movement disorders (Parkinson's disease, essential tremor, dyskinesia, myoclonus) and other non-neurological conditions (tic disorders, torticollis, ulnar nerve entrapments, temporomandibular disorders, dysphonia) that mimic dystonic symptoms.
Exclusion criteria:
Patients who are incapable of giving informed consent;
Patients who are unable to undergo brain MRI due to the presence of certain tattoos and ferromagnetic objects in their bodies (e.g., implanted stimulators, surgical clips, prosthesis, artificial heart valve) that cannot be removed or due to pregnancy or breastfeeding at the time of the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kristina Simonyan, MD, PhD
Phone
617-573-6016
Email
simonyan_lab@meei.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristina Simonyan, MD, PhD
Organizational Affiliation
Massachusetts Eye and Ear
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts Eye and Ear Infirmary
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristina Simonyan, MD, PhD
Phone
617-573-6016
Email
simonyan_lab@meei.harvard.edu
12. IPD Sharing Statement
Learn more about this trial
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
We'll reach out to this number within 24 hrs